Načítá se...
Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
Patients with HCV-related bridging fibrosis or cirrhosis remain at risk of developing life-threatening complications even after achieving a sustained virological response. Although it is reduced, the risk of liver-related events in these patients justifies their inclusion in surveillance programmes...
Uloženo v:
| Vydáno v: | JHEP Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7005771/ https://ncbi.nlm.nih.gov/pubmed/32039400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2019.11.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|